Margaret Doyle

Margaret Doyle is a Senior Global Medical Affairs Leader at Johnson & Johnson Innovative Medicine, with global responsibility for scientific strategy in multiple myeloma. Based in Ireland, she brings a strong Irish connection alongside a global perspective, working at the interface of science, clinical practice, and health policy to translate innovation into improved patient outcomes across regions internationally to address unmet needs in cancer care.
Her work spans early and latephase evidence generation, realworld data, and engagement with evolving standards of care, with a particular emphasis on ensuring that scientific advances are matched by timely and equitable patient access to innovative therapies.